Incytevs.United Therapeutics
INCY vs UTHR · both in Biotech & innovation, part of the Medicine, pharma & life science value chain: Innovation-driven biotech companies focused on novel treatment modalities.
Incyte and United Therapeutics are similar in size by market cap; Incyte trades at the lower P/E (16.1 vs 18.0); year to date, Incyte leads (+18.2% vs +12.3%).
Side by side
| INCY | UTHR | |
|---|---|---|
| Market cap | $23.1B | $23.2B |
| Price | $116.71 | $547.06 |
| Today | −1.5% | −1.0% |
| Return YTD | +18.2% | +12.3% |
| Return 1Y | +65.9% | +82.3% |
| P/E | 16.1 | 18.0 |
| P/S | 4.3 | 7.3 |
| P/B | 4.1 | 3.9 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
United TherapeuticsUTHR
Biopharma in pulmonary hypertension and organ manufacturing (xenotransplantation).
Full UTHR profile →More comparisons in Biotech & innovation
See where INCY and UTHR sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →